FPBFACDWOSWVSH-UHFFFAOYSA-N
C31H28Cl2F2N8O2 — CID 123244903
Data last refreshed: (MolForge compound catalog, from PubChem)
About FPBFACDWOSWVSH-UHFFFAOYSA-N
FPBFACDWOSWVSH-UHFFFAOYSA-N (PubChem CID 123244903) has the molecular formula C31H28Cl2F2N8O2 and a molecular weight of 653.52 g/mol. Its IUPAC name is 13-[4-[5-chloro-2-(4-chlorotriazol-1-yl)phenyl]-6-oxo-2,3-dihydropyridin-1-yl]-3-(2,2-difluorocyclopropyl)-9-methyl-3,4,7,15-tetrazatricyclo[12.3.1.02,6]octadeca-1(18),2(6),4,14,16-pentaen-8-one.
Molecular Properties
| Compound Name | FPBFACDWOSWVSH-UHFFFAOYSA-N |
|---|---|
| PubChem CID | 123244903 |
| Molecular Formula | C31H28Cl2F2N8O2 |
| Molecular Weight | 653.52 g/mol |
| Exact Mass | 652.17 |
| IUPAC Name | 13-[4-[5-chloro-2-(4-chlorotriazol-1-yl)phenyl]-6-oxo-2,3-dihydropyridin-1-yl]-3-(2,2-difluorocyclopropyl)-9-methyl-3,4,7,15-tetrazatricyclo[12.3.1.02,6]octadeca-1(18),2(6),4,14,16-pentaen-8-one |
| SMILES | CC1CCCC(N2CCC(c3cc(Cl)ccc3-n3cc(Cl)nn3)=CC2=O)c2cc(ccn2)-c2c(cnn2C2CC2(F)F)NC1=O |
| InChI | InChI=1S/C31H28Cl2F2N8O2/c1-17-3-2-4-25(22-11-19(7-9-36-22)29-23(38-30(17)45)15-37-43(29)26-14-31(26,34)35)41-10-8-18(12-28(41)44)21-13-20(32)5-6-24(21)42-16-27(33)39-40-42/h5-7,9,11-13,15-17,25-26H,2-4,8,10,14H2,1H3,(H,38,45) |
| InChIKey | FPBFACDWOSWVSH-UHFFFAOYSA-N |
| XLogP | 6.53 |
| TPSA | 110.83 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 8 |
| Rotatable Bonds | 4 |
| Heavy Atoms | 45 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 653.52 |
| LogP ≤ 5 | 6.53 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 8 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 123244903 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.